MARINUS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.600 USD | +5.96% |
|
+15.11% | -85.28% |
| Aug. 14 | Ladenburg Thalmann Downgrades Marinus Pharmaceuticals to Neutral From Buy | MT |
| Aug. 13 | Marinus Pharmaceuticals, Inc., Q2 2024 Earnings Call, Aug 13, 2024 |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | 1st Jan change | 1-year change | 3-years change | 5-years change | 10-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +5.96% | +15.11% | +26.98% | +14.70% | -85.28% | -72.70% | -86.73% | -74.52% | -94.60% | 85.38M | ||
| +1.11% | -0.64% | -0.77% | +2.65% | +56.98% | +60.17% | +297.67% | +711.78% | +1,274.14% | 816B | ||
| +1.81% | +0.86% | -2.26% | -8.46% | +28.66% | +38.10% | +179.20% | +419.57% | +537.93% | 583B | ||
| -0.80% | 0.00% | +3.41% | +13.16% | +5.16% | +1.45% | +0.04% | +26.39% | +53.54% | 402B | ||
| +0.35% | -0.50% | -0.14% | +12.99% | +24.94% | +25.78% | +79.73% | +171.67% | +225.69% | 342B | ||
| -1.19% | +2.20% | +3.13% | -8.41% | +7.53% | +8.73% | +63.55% | +41.21% | +94.38% | 300B | ||
| -0.34% | -0.48% | -4.91% | +7.91% | +9.41% | +3.70% | -21.99% | -4.99% | -5.58% | 255B | ||
| +0.35% | -3.33% | -8.80% | -4.17% | +12.25% | +10.91% | +47.56% | +71.27% | +162.27% | 243B | ||
| +0.41% | +1.00% | -1.04% | +5.68% | +15.99% | +6.98% | +27.12% | +14.76% | +11.29% | 235B | ||
| +0.91% | +1.81% | +4.51% | +9.79% | +16.64% | +27.66% | +53.14% | +72.25% | +136.55% | 179B | ||
| -0.30% | 0.00% | +4.81% | +8.21% | +3.02% | -11.83% | -32.42% | -18.47% | -3.01% | 169B | ||
| +1.13% | -0.42% | +5.63% | +17.64% | +16.00% | +2.40% | +27.68% | +29.79% | +17.70% | 143B | ||
| +0.01% | +3.66% | +13.72% | +32.86% | +3.57% | +10.95% | +17.16% | +27.66% | -20.80% | 103B | ||
| -1.45% | +0.88% | -0.69% | +20.12% | -4.46% | -16.32% | -20.05% | -1.68% | -4.11% | 100B | ||
| -1.84% | -4.84% | -1.04% | -2.33% | +8.57% | +4.59% | -9.26% | -23.52% | -12.31% | 86.4B | ||
| +0.80% | +5.06% | -0.76% | +34.84% | +27.44% | +50.39% | +62.21% | +164.56% | +541.26% | 78.3B | ||
| +1.12% | -4.83% | -16.99% | -6.80% | +27.84% | +20.06% | +76.50% | +111.18% | +716.16% | 65.55B | ||
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | ||
| -1.46% | -0.76% | +5.62% | +20.31% | +21.56% | +19.33% | - | - | - | 47.78B | ||
| +1.33% | +1.62% | -1.41% | +5.42% | +5.16% | -12.28% | +11.80% | +13.92% | -12.30% | 46.97B | ||
| Average | +0.35% | +0.47% | +1.53% | +9.27% | +10.58% | +9.37% | +42.94% | +97.38% | +201.01% | 212.96B | |
| Weighted average by Cap. | +0.17% | -0.37% | -0.14% | +5.05% | +23.09% | +23.20% | +102.07% | +231.95% | +393.56% |
- Stock Market
- Equities
- MRNS Stock
- Sector Marinus Pharmaceuticals, Inc.
